Life Sciences

This issue profiles 3D bioprinting for breast cancer reconstruction of nipple areola complex, enablement of cardiovascular tissue using extracellular matrix-based technology, and a experimental technique for development of whole organs

This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.

This issue profiles research by Sandia for boosting thermoelectric nanowire efficiency, gold nanoprobes for cancer diagnostics, and Sandia research on converting biological cells to stone

This issue profiles a fully integrated, high capacity, next generation sequencing system; an ebola diagnostic kit by China that has been approved by the WHO; and CRISPR associated protein 9 mediated gene editing in human embryo.

This issue profiles recent advances and opportunities for innovation in drug-eluting stents.

This issue profiles a molecular pathway that holds the key to suppress children's cancer, destroying chemical weapons safely, and R&D on datacenter cabling at HP Laboratories.

This issue profiles an affordable and customisable radiotherapy system, a remote telerobotic ultrasound imaging platform, and affordable digital radiography systems for low-income countries.

This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...